As the HIV/AIDS epidemic took hold in Africa in the 1990s, researchers studying ways to treat and prevent the disease struggled with the ethical questions involved. Was it appropriate to use placebos in trials of drugs that were already proven effective in high-income countries? How could they ensure research subjects were not unduly influenced into participation when the alternative in many cases was no treatment at all? How could investigators clearly communicate the potential risks to populations with little education and low literacy?

Photo by Richard Lord for Fogarty

Fogarty is helping to plan the next phase of the Medical Education Partnership Initiative (MEPI) to continue to  build health and science capacity in Africa.

Fogarty is working with its partners to plan how to build on the success of the Medical Education Partnership Initiative (MEPI) and continue to strengthen and expand capacity building in sub-Saharan Africa. The Center has released two new program concepts that outline possible next steps.